Cooperative Agreement 2111755
Award Date 8/1/21
Completion Date 1/31/24
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Dorchester, MA 02125, USA
Similar Awards
- This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I Project Grant, awarded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $304,966 to support the development of a portable, rapid point-of-care diagnostic device capable of simultaneously detecting and quantifying multiple blood-based biomarkers. The project aims to create an integrated cartridge/analyzer system that can automate serum separation and buffer dilution to...
- The National Science Foundation (NSF) awarded a $1,193,767 Cooperative Agreement under the Technology, Innovation, and Partnerships (CFDA 47.084) program to Xheme Inc., a for-profit company in Newton, MA. The grant supports the development of a novel, non-toxic blood bag technology to replace outdated polyvinyl chloride (PVC) bags that contain hazardous plasticizers. The project aims to create a next-generation composite blood bag that eliminates harmful leaching substances while meeting...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...
- This Cooperative Agreement award, funded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a bioprocessing system to isolate and purify therapeutic antibodies directly from cell culture. The $999,998 award to Athem LLC, a minority-owned small business, will enable scaling up a novel nanoparticle-based purification media and an automated prototype system. The goal is to simplify the manufacturing of biologics, reduce...
- The National Science Foundation (NSF) awarded a $1,250,000 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to Micropure Genomics Inc., a minority-owned small business located in Middletown, Delaware. The project aims to develop an innovative, automated platform for preparing high-quality DNA samples to support long-read sequencing technologies. The platform will deliver improved reproducibility, reduced preparation time, and lower costs...
- The National Science Foundation (NSF) has awarded a $305,000 SBIR Phase I project grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Plexymer, Inc. for the development of an AI-directed automation system to accelerate the bioformulation of antibody therapeutics. The project aims to enable the transformation of hospital-administered antibody infusions into self-administered at-home injections by pairing laboratory robotics with artificial intelligence to...
- This $256,000 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program will support the development of a universal connector for high-density microfluidic chip interfaces by Neptune Fluid Flow Systems LLC. The proposed connector aims to advance lab-on-a-chip and other life science platforms by introducing a standardized microfluidic chip interface. This new interface seeks to dramatically increase diagnostic testing speeds for doctors and medical...
- This $305,000 STTR Phase I Project Grant awarded by the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an ultra-sensitive biosensor capable of protein analysis at single-molecule resolution. The biosensor consists of a nanopatterned chip with a proprietary scaffold material that binds and immobilizes molecular targets, which are then detected using surface-enhanced Raman spectroscopy (SERS). This innovation seeks...
- The National Science Foundation (NSF) awarded a $2,375,361 Cooperative Agreement to Koliber Biosciences Inc. under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop computational tools that leverage artificial intelligence and machine learning to design improved protein "transporter" molecules. These transporter proteins control the movement of valuable chemicals in and out of cells, which is a critical limitation in microbial...
- This SBIR Phase I award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $273,550 to Biocognon LLC for the development of a combinatorial platform to discover improved molecular recognition components for use in therapeutic and diagnostic antibodies. The project aims to utilize synthetic biology, next-generation DNA sequencing, and computational biology to efficiently generate and screen libraries of antibody...